Enteropathy in inborn and acquired errors of immunity: histological patterns and clinical correlates
Related Experiment Video
Updated: Oct 31, 2026

A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development
Published on: June 24, 2020
Meera Thangarajah1,2,3,4, Samar Ojaimi4,5,6, Alisa Kane4,7,8,9,10
1Faculty of medicine and health, University of Sydney, Sydney, NSW, Australia.
Introduction:
Enteropathy is a significant and under-recognised complication of inborn errors of immunity (IEI), frequently misclassified as inflammatory bowel disease (IBD) or coeliac disease due to overlapping and non-specific histopathological findings. Diagnostic criteria remain poorly defined, contributing to substantial diagnostic delay and associated morbidity.
Methods:
We conducted a structured literature review and established the AT-SEA (Adult Tertiary Severe Enteropathy Audit) working group, a collaborative network of Australian clinical immunologists operating under the Clinical Immunogenomics Research Consortium Australasia (CIRCA), to characterise the clinicopathological features of IEI-associated enteropathy across a multicentre cohort.
Results:
Twenty-eight patients were identified. Moderate or severe disease was present in 89%, with malabsorption in 71% and protein-losing enteropathy in 43%. Across 48 biopsy reports, the most frequent histopathological patterns were coeliac-like changes (including villous atrophy, increased intraepithelial lymphocytes and crypt hyperplasia), IBD-like changes, reduced or absent plasma cells, graft versus host disease (GVHD)-like changes or increased apoptotic bodies and intraepithelial neutrophilia. Seventy-seven percent of patients demonstrated two or more concurrent patterns. Increasing histological complexity correlated significantly with clinician-assessed disease severity (Kruskal-Wallis p=0.042).
Discussion:
IEI-associated enteropathy is characterised by overlapping and evolving histopathological patterns rather than discrete subtypes. The co-occurrence of multiple patterns should prompt consideration of an underlying IEI.
More Related Videos
06:57Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells
Published on: September 18, 2016
08:24Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
Amebiasis
Inflammatory Bowel Disease II: Ulcerative Colitis
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...